Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Acumen Pharmaceuticals Inc.
DescriptionHumanized lgG2 mAb
Molecular Target Amyloid-beta derived diffusible ligands (ADDLS)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationAlzheimer's disease (AD)
Indication DetailsTreat Alzheimer's disease (AD)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today